The relationship between risk factor levels and presence of coronary artery calcification is dependent on Apolipoprotein E genotype

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 2, 1999, Pages 427-435

  Kardia, Sharon L R ^a   Haviland, M B ^a   Ferrell, R E ^b   Sing, C F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atherosclerosis; Calcium; Computed tomography; Genetics; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; ELECTRON BEAM TOMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032968279     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.2.427     Document Type: Article

References (56)

1. American Heart Association. Heart and Stroke Facts Statistics: 1996 Statistical Supplement. Dallas, Tex: American Heart Association National Center; 1996.
2. Hopkirk JA, Uhl GS, Hickman JR Jr, Fischer J, Medina A. Discriminant value of clinical and exercise variables in detecting significant coronary artery disease in asymptomatic men. J Am Coll Cardiol. 1984;3:887-894.
3. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA. 1953;256:2859-2862.
4. Blankenhorn D. Coronary arterial calcification: a review. Am J Med Sci. 1961;242:41-49.
5. McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA. 1971;216:1185-1187.
6. Bartel AG, Chen JT, Peter RH, Behar VS, Kong Y, Lester RG. The significance of coronary calcification detected by fluoroscopy. Circulation. 1974;49:1247-1253.
7. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Noninvasive definition of anatomic coronary artery disease by ultra fast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992;20:1118-1126.
8. Detrano RC, Wong ND, Tang W, French WJ, Georgiou D, Young E, Brezden OS, Doherty TM, Narahara KA, Brundage BH. Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol. 1994;24:354-358.
9. Puentes G, Detrano R, Tang W, Wong N, French W, Narahara K, Brundage B, Baksheshi H. Estimation of coronary calcium mass using electron beam computed tomography: a promising approach for predicting coronary events? Am J Card Imaging. 1995;9(suppl 1):5. Abstract.
10. Detrano R, Hsiai T, Wang S, Puentes G, Fallavollita J, Shields P, Stanford W, Wolfkiel C, Georgiou D, Budoff M, Reed J. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol. 1996;27:285-290.
11. Enholm C, Lukka M, Kuusi C, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 1986;27:227-235.
12. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man, II: the role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Hum Genet. 1987;27:567-582.
13. Havekes LM, de Knijff P, Smit M, Frants R. The effect of apolipoprotein E allele substitutions on plasma lipid and apolipoprotein levels. Adv Exp Med Biol. 1988;243:87-93.
14. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoprotein E, A-IV, and H on quantitative traits related to risk of cardiovascular disease. Arterioscler Thromb. 1991;11: 1330-1348.
15. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb. 1991; 11:1100-1110.
16. Davignon J, Gregg RR, Sing CF. ApoE polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
17. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 1992;9:155-167.
18. Kuusi T, Nieminen MS, Ehnholm C, Yki-Jarvinen H, Valle M, Nikkila EA, Taskinen MR. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E4 in angiographically verified coronary patients. Arteriosclerosis. 1989;9:237-241.
19. Davignon J. Apolipoprotein E polymorphism and atherosclerosis. In: Born GVR, Schwartz CJ, eds. New Horizons in Coronary Heart Disease. London: Current Science; 1993:5.1-5.2.
20. Luc G, Bard J, Arveiler D, Evans A, Cambou J, Bingham A, Amouyel P, Schaffer P, Ruidavets J, Cambien F, Fruchart J, Ducimetiere P. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM Study. Arterioscler Thromb. 1994;14:1412-1419.
21. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272:1666-1671.
22. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91:265-269.
23. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Arteriosclerosis. 1983;3:310-315.
24. Stuyt PMJ, Brenninkmeijer BJ, Demacker PNM, Hendriks JCM, Van Elteren P, Stalenhoef AFH, Van't Laar A. Apolipoprotein E phenotypes, serum lipoproteins and apolipoprotein in angiographically assessed coronary heart disease. Scand J Clin Lab Invest. 1991;51:425-435.
25. Payne MN, Green E, Walker MR, Beattie JM, Murray RG, Jones AF. Apolipoprotein E4 and coronary artery disease. Lancet. 1992;340:1350. Letter.
26. Lehtinen S, Lehtimäki T, Sisto T, Salenius J-P, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 1995;114:83-91.
27. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary disease. Clin Chem. 1986;32:778-781.
28. Hanis CL, Hewett-Emmett D, Douglas TC, Bertin TK, Schull WJ. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler Thromb. 1991;11:362-370.
29. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the populations of Rochester, Minnesota, II: regression relationships with concomitants. Am J Hum Genet. 1992;51:1311-1324.
30. Srinivasan SR, Ehnholm C, Wattigney WA, Berenson GS. Relationship between obesity and serum lipoproteins in children with different apolipoprotein E phenotypes: the Bogalusa Heart Study. Metabolism. 1994; 43:470-475.
31. Zerba KE, Ferrell RE, Sing CF. Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human. Genetics. 1996;143:463-478.
32. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN, III: correlations and covariances. Am J Hum Genet. 1994;55:1001-1018.
33. Haviland MB, Lussier-Cacan S, Davignon J, Sing CF. Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. Am J Med Genet. 1995;58:315-331.
34. Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL, Fuller T, Sing CF. Distribution of sodium-lithium countertransport and blood pressure in Caucasian five to eighty-nine years of age. Hypertension. 1989;13:378-391.
35. Moll PP, Michels VV, Wiedman WH, Kottke BA. Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet. 1989;44:124-139.
36. Maher JA, Raz JA, Bielak LP, Sheedy PF, Schwartz RS, Peyser PA. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol. 1996;144:943-953.
37. Kottke BA, Moll PP, Michels VV, Weidman WH. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc. 1991;66:1198-1208.
38. Izzo C, Grillo F, Murador E. Improved method for determination of high-density-lipoprotein cholesterol, I: isolation of high density lipoproteins by use of polyethylene glycol-6000. Clin Chem. 1981;27: 371-374.
39. Kamboh MI, Ferrell RE, Sepehrnia B. Genetic studies of human apolipoproteins, IV: structural heterogeneity of apolipoprotein h (beta-2 glycoprotein 1). Am J Hum Genet. 1988;42:452-457.
40. Mailly F, Moll PP, Kottke BA, Kamboh MI, Humphries SE, Ferrell RE. Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms. Genet Epidemiol. 1992;9:239-248.
41. Kauffman RB, Sheedy PF, Breen JF, Kelzenberg JR, Kruger BL, Schwartz RS, Moll PP. Detection of heart calcification with electron beam CT: interobserver and intraobserver reliability for scoring quantification. Radiology. 1994;190:347-352.
42. Agaston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultra fast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
43. Satterthwaite FE. An approximate distribution of estimates of variance components. Biometrics Bull. 1946;2:110-114.
44. Cumming AM, Robertson F. Polymorphism at the apo E locus in relation to risk of coronary disease. Clin Genet. 1984;25:310-313.
45. Kuusi T, Nieminen MS, Ehnholm C, Yki-Karvinen H, Valle M, Nikkila EA, Taskinen M. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 1989;9:237-241.
46. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet. 1992;340: 879-880.
47. Nieminen MS, Mattila KJ, Aalto-Setala K, Kuusi T, Kontula K, Kauppinen-Makelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen M-R. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb. 1992;12:58-69.
48. Utermann G, Hardewig A, Zimmer F. ApoE phenotypes in patients with myocardial infarction. Hum Genet. 1984;65:237-241.
49. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein 2 and 4 alleles in patients with ischemic heart disease. Clin Genet. 1989; 36:183-188.
50. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. The relationship of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160-165.
51. de Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet. 1995;56:1379-1390.
52. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1991;11:1237-1244.
53. Scheer WD, Boudreau DA, Malcom GT, Middaugh JP. Apolipoprotein E and atherosclerosis in Alaska natives. Atherosclerosis. 1995;114:197-202.
54. Sing CF, Haviland MB, Reilly SL. Genetic architecture of common multifactorial diseases. In: Chadwick D, Cardew G, eds. Variation in the Human Genome. Ciba Foundation Symposia 197. Chichester, UK: John Wiley and Sons. 1996:211-232.
55. Bar-Yam Y. Dynamics of complex systems. Reading, Mass: Addison-Wesley; 1997:12.
56. Weiss KM. Genetic Variation and Human Disease: Principles and Evolutionary Approaches. Cambridge, UK: Cambridge University Press; 1993.